Peer Review reports
From: p90RSK pathway inhibition synergizes with cisplatin in TMEM16A overexpressing head and neck cancer
| Original Submission | ||
|---|---|---|
| 14 Aug 2023 | Submitted | Original manuscript |
| Resubmission - Version 2 | ||
| Submitted | Manuscript version 2 | |
| Resubmission - Version 3 | ||
| Submitted | Manuscript version 3 | |
| 25 Sep 2023 | Reviewed | Reviewer Report - Nabil M. Abdelfattah |
| 23 Oct 2023 | Reviewed | Reviewer Report - Aviram Mizrachi |
| 10 Nov 2023 | Reviewed | Reviewer Report |
| 24 Nov 2023 | Author responded | Author comments - Umamaheswar Duvvuri |
| Resubmission - Version 4 | ||
| 24 Nov 2023 | Submitted | Manuscript version 4 |
| 26 Nov 2023 | Author responded | Author comments - Umamaheswar Duvvuri |
| Resubmission - Version 5 | ||
| 26 Nov 2023 | Submitted | Manuscript version 5 |
| 15 Dec 2023 | Reviewed | Reviewer Report - Nabil M. Abdelfattah |
| 13 Jan 2024 | Reviewed | Reviewer Report - Aviram Mizrachi |
| Resubmission - Version 6 | ||
| Submitted | Manuscript version 6 | |
| Publishing | ||
| 17 Jan 2024 | Editorially accepted | |
| 19 Feb 2024 | Article published | 10.1186/s12885-024-11892-9 |
You can find further information about peer review here.